Abstract
Introduction: Severe neutropenia and infections are frequent adverse events associated with standard chemotherapy regimens. We tightly monitored absolute neutrophil counts (ANCs) in a patient population undergoing anthracycline and cyclophosphamide treatment. Results prompt us to recommend apposite time points to monitor ANCs. Methods: MyeloConcept is a randomized, double-blind,
Keywords